Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid Corp. shares rose 1.3% in Thursday premarket trading after the pharmacy retailer reported a fourth-quarter sales beat. Net losses totaled $18.5 million, or 34 cents per share, after a loss of $324.7 million, or $6.08 per share, last year.

Rite Aid reports narrower losses, sales beat

Shares of Rite Aid (NYSE:RAD) fell 0.4% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 110.81% year over year to ($0.78), which missed the estimate of ($0.76).

Recap: Rite Aid Q4 Earnings

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its fourth quarter and fiscal year ended February 27, 2021. For the fourth quarter, the company reported net loss from continuing operations of $18.5 million, or $0.34 loss per share, Adjusted net loss from continuing operations of $41.8 million, or $0.78 loss per share, and Adjusted EBITDA from continuing operations of $41.3 million, or 0.7 percent of revenues. “We remain very optimistic abou

Rite Aid Corporation Reports Fiscal 2021 Fourth Quarter and Full Year Results

Delta Air Lines

PepsiCo

United Continental Hlds

The first big week of the new earnings season continues with several big companies reporting earnings before Thursday's opening bell.

Earnings Previews: Delta Air Lines, PepsiCo, Rite Aid and More

Solid performance in PBM and Elixir along with expanded omnichannel services is expected to have aided Rite Aid's (RAD) Q4 revenues. However, COVID-19 woes remain concerns.

Factors Likely to Influence Rite Aid's (RAD) Q4 Earnings

Deutsche Bank raises price target on RAD to $27. US government increases vaccine reimbursement from $28 to $40 per dose.

Rite Aid Remains On Track Despite Projected Q4 EBITDA Miss

KB Home

A Look at What's Going on With RH, KB Home, and Rite Aid

Social distancing has dampened demand for cold and flu medicine.

Why Rite Aid Stock Plunged Today

Netflix

Walgreens

Affirm

Esports Entertainment Group

Horizon Technology Finance

Vail Resorts

PetroChina Company Ltd.

With the trading day more than halfway over, the broad markets were trading sideways. The Dow Jones industrial average and S&P 500 were each more or less flat on the day, while the Nasdaq was lagging yet again.

Esports, Netflix, Rite Aid, Vail, Walgreens and More Thursday Afternoon Analyst Calls

Shares of Rite Aid tumbled almost 20 percent on Thursday (March 25) after the pharmacy chain said that a nearly 40 percent decline in its high-margin cough, cold and flu remedies business this winter “significantly impacted” its quarterly results. The earnings and revenue pre-announcement by the operator of 2,400 stores in 17 states came just […]

Rite Aid Hurt By Weak Cold & Flu Season; Pre-Announces $60 Million Shortfall

Adverse COVID-19 impacts, lesser cases of cold, cough and flu and unfavorable weather weighed on Rite Aid's (RAD) Q4 results. Also, it updated fiscal 2021 view.

Rite Aid (RAD) Stock Plunges on Bleak Q4 Business Update

The stock price of Rite Aid Corporation (NYSE: RAD) fell by over 15% pre-market. This is why it happened.

RAD Stock Price Falls Over 15% Pre-Market: Why It Happened

Rite Aid fell by as much as 20% in pre-market trading on Thursday, after the company said its full-year results would be undermined by declining numbers of people falling sick with colds and coughs. The retail drugstore industry has been hit by a weak sales season, due to measures to curtail the spread of coronavirus, the company said. As a result of physical distancing, face masks, and use of sanitizers, Rite Aid said it saw a decline of nearly 37% in its cough, cold, and flu-related product categories.

Rite Aid plunges 20% after cutting its full-year forecast as the drugstore chain saw fewer people getting colds and coughs

Rite Aid warned of a soft cold and flu season that's going to hit the company's bottom line worse than expected for its fiscal 2021.

Rite Aid: ‘Soft Cough, Cold And Flu Season' Triggers Bigger Annual Loss Than Expected

Shares of Rite Aid Corp. fell more than 18% in the extended session Wednesday after the drugstore chain lowered its guidance for fiscal 2021, saying its bottom line was "significantly" hampered by a "soft" cold and flu season, the ongoing pandemic, and "challenging" weather. Same-store sales fell about 5.6% in the quarter ended in February, mostly due to a decline of nearly 37% percent in cough, cold and flu-related categories, the company said.

Rite Aid stock down 18% after lower 2021 guidance on 'soft' flu season

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation's (NYSE: RAD) fourth quarter 2021 financial results were significantly impacted by a soft cough, cold and flu season, ongoing impacts related to COVID-19 and challenging weather conditions. As a result, the Company is updating its guidance for the fiscal year ended February 27, 2021. “During the fourth quarter our industry was impacted by a historically soft cough, cold and flu season, as well as the continued impacts of COVID on the deferra

Rite Aid Provides Update on Fiscal Year 2021 Guidance

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid today announced it has extended the priority COVID-19 vaccine scheduling period for teachers, school staff and childcare providers, in accordance with a directive from the United States Department of Health and Human Services (HHS) and the Biden Administration, to ensure these groups are vaccinated during the month of March. Continuing last week's initiative, the scheduling of select COVID-19 vaccine appointments at Rite Aid will be available exclusivel

Rite Aid Extends COVID-19 Vaccine Priority Scheduling Period for Teachers, School Staff and Childcare Providers

Rite Aid has a growing retail pharmacy business generating over $15 billion in annual revenues. RAD owns a Prescription Benefits Management (PBM) service, now known as Elixir, currently generating an additional $8 billion in annual revenues.

Rite Aid, No Matter How You Cut It, It Is The Right Stock

Penn Entertainment

CleanSpark

CrowdStrike

Penn National Gaming, CrowdStrike, Rite Aid and CleanSpark were our top stock trades for Wednesday. Now, let's get a look at the charts.

4 Top Stock Trades for Wednesday: PENN, CRWD, RAD, CLSK

CAMP HILL, Pa.--(BUSINESS WIRE)--In accordance with a directive from the United States Department of Health and Human Services (HHS) and the Biden Administration, Rite Aid today announced expanded eligibility for COVID-19 vaccine appointments to pre-K to high school educators, school staff and licensed childcare program staff. To comply with the HHS directive to ensure teachers, school staff and childcare workers are vaccinated during the month of March, select COVID-19 vaccine appointments at

Rite Aid Expands and Prioritizes COVID-19 Vaccine Eligibility to Teachers, School Staff and Childcare Providers

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced expanded commitments to reduce toxic chemicals in the products it sells, doubling down on its efforts to ensure clean, safe product ingredients as part of the company's RxEvolution strategy. Rite Aid's commitment to improve chemical management and product safety directly aligns with the company's objective to help customers achieve whole health. Following an evaluation of current practices, Rite Aid has identified several new

Rite Aid Expands Commitment to Improving Chemical Management and Product Safety

Rite Aid Corp. said Thursday that as part of the Federal Retail Pharmacy Program, which launches Thursday, that will receive COVID-19 vaccines directly from the U.S. government in five states and two major cities. Participating stores in California, Michigan, New Jersey, Ohio and Pennsylvania, as well as New York City and Philadelphia, will receive 100 doses per week, with allocations to grow over time.

Rite Aid stores to receive 100 COVID-19 vaccines a week in 5 states and New York City, Philadelphia

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is expanding no-charge COVID-19 self-swab testing to all drive-through locations, with 441 additional sites opening Friday, February 12, through its partnership with the U.S. Department of Health and Human Services (HHS). The new testing sites will increase Rite Aid's capacity for COVID-19 testing services in California, Connecticut, Delaware, Idaho, Maryland, Michigan, New Hampshire, Ohio, Oregon, Virginia and Washington. Like Rite Aid's ex

Rite Aid Expands No-Charge COVID-19 Testing to All Drive-Through Locations

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is expanding its no-charge COVID-19 testing capabilities with 317 additional drive-through testing site locations opening across New Jersey, New York and Pennsylvania on Friday, February 5, through its partnership with the U.S. Department of Health and Human Services (HHS). Like Rite Aid's existing testing sites, the new locations will utilize PCR, simple self-swab nasal tests overseen by Rite Aid pharmacists. Each site will operate Monday t

Rite Aid Opens More Than 300 New No-Charge COVID-19 Testing Sites

Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?

News for Rite Aid Stock (RAD)